Vacuum Erection Devices Revisited: Its Emerging Role in the Treatment of Erectile Dysfunction and Early Penile Rehabilitation Following Prostate Cancer Therapy

Authors

  • Geetu Pahlajani MD,

    1. Department of Regional Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA;
    Search for more papers by this author
  • Rupesh Raina MD,

    1. Department of Regional Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA;
    2. Department of Internal Medicine and Pediatrics, Metro Health Medical Center, Case Western Reserve University, Cleveland, OH, USA
    Search for more papers by this author
  • Stephen Jones MD,

    1. Department of Regional Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA;
    Search for more papers by this author
  • Marwan Ali MD,

    1. Department of Regional Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA;
    Search for more papers by this author
  • Craig Zippe MD

    Corresponding author
    1. Department of Regional Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA;
      Craig Zippe, MD, Department of Regional Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44125, USA. Tel: 216-587-4370; Fax: 216-587-5560; E-mail: verdir@ccf.org
    Search for more papers by this author

Craig Zippe, MD, Department of Regional Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH 44125, USA. Tel: 216-587-4370; Fax: 216-587-5560; E-mail: verdir@ccf.org

ABSTRACT

Introduction.  Vacuum erection devices (VEDs) are becoming first-line therapies for the treatment of erectile dysfunction and preservation (rehabilitation) of erectile function following treatment for prostate cancer. Currently, there is limited efficacy of the use of phosphodiesterase type 5 inhibitors in elderly patients, or patients with moderate to severe diabetes, hypertension, and coronary artery disease.

Aim.  The article aims to study the role of VED in patients following prostate cancer therapy.

Results.  Alternative therapies such as VED have emerged as one of the primary options for patients refractory to oral therapy. VED has also been successfully used in combination treatment with oral therapy and penile injections. More recently, there has been interest in the use of VED in early intervention protocols to encourage corporeal rehabilitation and prevention of postradical prostatectomy veno-occlusive dysfunction. This is evident by the preservation of penile length and girth that is seen with early use of the VED following radical prostatectomy. There are ongoing studies to help preserve penile length and girth with early use of VED following prostate brachytherapy and external beam radiation for prostate cancer. Recently, there has also been interest in the use of VED to help maintain penile length following surgical correction of Peyronie's disease and to increase penile size prior to implantation of the penile prosthesis.

Conclusion.  VEDs can be one of the options for penile rehabilitation after prostate cancer therapy. Pahlajani G, Raina R, Jones S, Ali M, and Zippe C. Vacuum erection devices revisited: Its emerging role in the treatment of erectile dysfunction and early penile rehabilitation following prostate cancer therapy. J Sex Med 2012;9:1182–1189.

Ancillary